StonvexLoading…
StonvexCore line items from PR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.07B | $5.00B | $3.12B | $2.13B |
Operating Income | $1.46B | $1.74B | $1.10B | $1.01B |
Net Income | $935.17M | $984.70M | $476.31M | $515.04M |
EPS (Diluted) | $1.28 | $1.45 | $1.24 | $1.61 |
Total Assets | $17.91B | $16.90B | $14.97B | $8.49B |
Total Liabilities | $6.38B | $6.38B | $5.74B | $2.84B |
Cash & Equivalents | $153.69M | $479.34M | $73.29M | $59.55M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 751.75M | 703.77M | 540.79M | 288.53M |